Metallothionein Null Cells Have Increased Sensitivity to Anticancer Drugs

Cancer Research

Volumn 55, Issue 10, 1995, Pages 2021-2023

  Kondo, Yukihiro ^a   Woo, Elizabeth S ^a   Lazo, John S ^a,b   Michalska, Anna E ^c   Choo, K H Andy ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYTARABINE; DOXORUBICIN; MELPHALAN; METALLOTHIONEIN; METHYLNITRONITROSOGUANIDINE; ZINOSTATIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; FIBROBLAST CULTURE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMAL; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE; DNA; DNA DAMAGE; DRUG RESISTANCE; FIBROBLASTS; GENE EXPRESSION; MELPHALAN; METALLOTHIONEIN; METHYLNITRONITROSOGUANIDINE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029022588     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Basu, A., Teicher, B. A., and Lazo, J. S. Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diamminedichloroplatinum(II). J. Biol. Chem., 265: 8451–8457, 1990.
2. Zeng, J., Heuchel, R., Schaffner, W., and Kagi, J. H. Thionein (apometallothionein) can modulate DNA binding and transcription activation by zinc ringer containing factor Spl. FEBS Lett., 279: 310–312, 1991.
3. Li, T.-Y., Kraker, A. J., Shaw, C. F., III, and Petering, D. H. Ligand substitution reactions of metallothioneins with EDTA and apo-carbonic anhydrase. Proc. Natl. Acad. Sci. USA, 77: 6334–6338, 1980.
4. Kelley, S. L., Basu, A., Teicher, B. A., Hacker, M. P., Hamer, D. H., and Lazo, J. S. Overexpression of metallothionein confers resistance to anticancer drugs. Science (Washington DC), 241: 1813–1815, 1988.
5. Basu, A., and Lazo, J. S. Suppression of dexamethasone-induced metallothionein expression and ns-diamminedichloroplatinum(II) resistance by mos. Cancer Res., 57: 895–896, 1991.
6. Kaina, B., Lohrer, H., Karin, M., and Herrlich, P. Overexpressed human metallothionein IIA gene protects Chinese hamster ovary cells from killing by alkylating agents. Proc. Natl. Acad. Sci. USA, 87: 2710–2714, 1990.
7. Schilder, R. J., Hall, L., Monks, A., Handel, L. M., Fornace, A. J., Jr., Ozols, R. F., Fojo, A. T., and Hamilton, T. C. Metallothionein gene expression and resistance to cisplatin in human ovarian cancer. Int. J. Cancer, 45: 416–422, 1990.
8. Lohrer, H., Robson, T., Grindley, H., Foster, S., and Hall, A. Differential effects on cell killing in metallothionein overexpressing CHO mutant cell lines. Carcinogenesis (Lond.), 11; 1937–1941, 1990.
9. Robson, T., Hall, A., and Lohrer, H. Increased sensitivity of a Chinese hamster ovary cell line to alkylating agents after overexpression of the human metallothionein II-A gene. Mutat Res., 274: 177–185, 1992.
10. Michalska, A. E., and Choo, K. H. Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc. Natl. Acad. Sci. USA, 90: 8088–8092, 1993.
11. Masters, B. A., Kelly, E. J., Quaife, C. J., Brinster, R. L., and Palmiter, R. D. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Natl. Acad. Sci. USA, 91: 584–588, 1994.
12. Lazo, J. S., Kondo, Y., Dellapiazza, D., Michalska, A. E., Choo, K. H. A., and Pitt, B. R. Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes. J. Biol. Chem., 270: 5506–5510, 1995.
13. Gray, J. W., and Coffino, P. Cell cycle analysis by flow cytometry. Methods Enzymol., 58: 233–248, 1979.
14. Schwarz, M. A., Lazo, J. S., Yalowich, J. C., Reynolds, I., Kagan, V. E., Tyurin, V., Kim, Y. M., Watkins, S. C., and Pitt, B. R. Cytoplasmic metallothionein overexpression protects NIH 3T3 cells from terr-butyl hydroperoxide toxicity. J. Biol. Chem., 269: 15238–15243, 1994.
15. Chubatsu, L. S., and Meneghini, R. Metallothionein protects DNA from oxidative damage. Biochem J., 297: 193–198, 1993.
16. Leibbrandt, M. E., Khokha, R., and Koropatnick, J. Antisense down-regulation of metallothionein in a human monocytic cell line alters adherence, invasion, and the respiratory burst. Cell Growth & Differ., 5: 17–25, 1994.
17. Papathanasiou, M. A., Kerr, N. C. K., Robbins, J. H., McBride, O. W., Alamo, I., Jr., Barrett, S. F., Hickson, I. D., and Fornace, A., Jr. Induction by ionizing radiation of the gadd 45 gene in cultured human cells: lack of mediation by protein kinase C. Mol. Cell. Biol., 11: 1009–1016, 1991.
18. Chen, Q., Yu, H., Holbrook, N. J., and Stevens, J. L. Activation of the growth arrest and DNA damage-inducible gene gadd 153 by nephrotoxic cysteine conjugates and dithiothreitol. J. Biol. Chem., 267: 8207–8212, 1992.
19. Hockenbery, D. M., Oltvai, Z. N., Yin, X. M., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75: 241–251, 1993.
20. Murphy, B. J., Laderoute, K. R., Chin, R. J., and Sutherland, R. J. Metallothionein IIA is unregulated by hypoxia in human A431 squamous carcinoma cells. Cancer Res., 54: 5808–5810, 1994.